Salih Anas, Inoue Susumu, Onwuzurike Nkechi
Department of Combined Medicine-Pediatrics Residency Program, Hurley Medical Center, Flint, Michigan, USA.
Department of Pediatics, Hurley Medical Center, Flint, Michigan, USA.
BMJ Case Rep. 2018 Jan 23;2018:bcr-2017-222384. doi: 10.1136/bcr-2017-222384.
Rothmund-Thomson syndrome (RTS) is a rare autosomal recessive disorder with clinical features consisting of poikiloderma, skeletal abnormalities, sparse hair, absent or scanty eyelashes and eyebrows and short stature. Patients with RTS due to genetic mutations of genes carry a high risk of developing osteosarcoma during childhood. Because of this, early genetic diagnosis is important. Here, we describe a 14-year-old white boy who developed an erythematous rash on both cheeks before the age of 3 months and was noted to have absent eyelashes and scanty eyebrows. He was found to have compound heterozygous mutations of the gene alleles at the age of 6 months and was diagnosed to have RTS type II. He subsequently developed osteosarcoma at age 10 which was successfully treated, and currently he has been tumour free for over 3 years.
罗思蒙德 - 汤姆森综合征(RTS)是一种罕见的常染色体隐性疾病,其临床特征包括皮肤异色症、骨骼异常、头发稀疏、睫毛和眉毛缺失或稀少以及身材矮小。由于基因突变导致的RTS患者在儿童期患骨肉瘤的风险很高。因此,早期基因诊断很重要。在此,我们描述一名14岁的白人男孩,他在3个月大之前双侧脸颊出现红斑疹,且被发现睫毛缺失、眉毛稀少。他在6个月大时被发现基因等位基因存在复合杂合突变,并被诊断为II型RTS。他随后在10岁时患上骨肉瘤,经成功治疗,目前已无瘤超过3年。